Cargando…

Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia

AIM: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Vorselaars, V. M. M., Velthuis, S., Huitema, M. P., Hosman, A. E., Westermann, C. J. J., Snijder, R. J., Mager, J. J., Post, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876176/
https://www.ncbi.nlm.nih.gov/pubmed/29497946
http://dx.doi.org/10.1007/s12471-018-1094-4
_version_ 1783310463260426240
author Vorselaars, V. M. M.
Velthuis, S.
Huitema, M. P.
Hosman, A. E.
Westermann, C. J. J.
Snijder, R. J.
Mager, J. J.
Post, M. C.
author_facet Vorselaars, V. M. M.
Velthuis, S.
Huitema, M. P.
Hosman, A. E.
Westermann, C. J. J.
Snijder, R. J.
Mager, J. J.
Post, M. C.
author_sort Vorselaars, V. M. M.
collection PubMed
description AIM: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this diagnostic test. Therefore, this study aimed to describe inter-observer and inter-injection variability of TTCE. METHODS: We conducted a prospective single centre study. We included all consecutive persons screened for presence of PAVMs in association with hereditary haemorrhagic telangiectasia in 2015. The videos of two contrast injections per patient were divided and reviewed by two cardiologists blinded for patient data. Pulmonary right-to-left shunts were graded using a three-grade scale. Inter-observer and inter-injection agreement was calculated with κ statistics for the presence and grade of pulmonary right-to-left shunts. RESULTS: We included 107 persons (accounting for 214 injections) (49.5% male, mean age 45.0 ± 16.6 years). A pulmonary right-to-left shunt was present in 136 (63.6%) and 131 (61.2%) injections for observer 1 and 2, respectively. Inter-injection agreement for the presence of pulmonary right-to-left shunts was 0.96 (95% confidence interval (CI) 0.9–1.0) and 0.98 (95% CI 0.94–1.00) for observer 1 and 2, respectively. Inter-injection agreement for pulmonary right-to-left shunt grade was 0.96 (95% CI 0.93–0.99) and 0.95 (95% CI 0.92–0.98) respectively. There was disagreement in right-to-left shunt grade between the contrast injections in 11 patients (10.3%). Inter-observer variability for presence and grade of the pulmonary right-to-left shunt was 0.95 (95% CI 0.91–0.99) and 0.97 (95% CI 0.95–0.99) respectively. CONCLUSION: TTCE has an excellent inter-injection and inter-observer agreement for both the presence and grade of pulmonary right-to-left shunts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12471-018-1094-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5876176
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bohn Stafleu van Loghum
record_format MEDLINE/PubMed
spelling pubmed-58761762018-03-30 Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia Vorselaars, V. M. M. Velthuis, S. Huitema, M. P. Hosman, A. E. Westermann, C. J. J. Snijder, R. J. Mager, J. J. Post, M. C. Neth Heart J Original Article AIM: Transthoracic contrast echocardiography (TTCE) is recommended for screening of pulmonary arteriovenous malformations (PAVMs) in hereditary haemorrhagic telangiectasia. Shunt quantification is used to find treatable PAVMs. So far, there has been no study investigating the reproducibility of this diagnostic test. Therefore, this study aimed to describe inter-observer and inter-injection variability of TTCE. METHODS: We conducted a prospective single centre study. We included all consecutive persons screened for presence of PAVMs in association with hereditary haemorrhagic telangiectasia in 2015. The videos of two contrast injections per patient were divided and reviewed by two cardiologists blinded for patient data. Pulmonary right-to-left shunts were graded using a three-grade scale. Inter-observer and inter-injection agreement was calculated with κ statistics for the presence and grade of pulmonary right-to-left shunts. RESULTS: We included 107 persons (accounting for 214 injections) (49.5% male, mean age 45.0 ± 16.6 years). A pulmonary right-to-left shunt was present in 136 (63.6%) and 131 (61.2%) injections for observer 1 and 2, respectively. Inter-injection agreement for the presence of pulmonary right-to-left shunts was 0.96 (95% confidence interval (CI) 0.9–1.0) and 0.98 (95% CI 0.94–1.00) for observer 1 and 2, respectively. Inter-injection agreement for pulmonary right-to-left shunt grade was 0.96 (95% CI 0.93–0.99) and 0.95 (95% CI 0.92–0.98) respectively. There was disagreement in right-to-left shunt grade between the contrast injections in 11 patients (10.3%). Inter-observer variability for presence and grade of the pulmonary right-to-left shunt was 0.95 (95% CI 0.91–0.99) and 0.97 (95% CI 0.95–0.99) respectively. CONCLUSION: TTCE has an excellent inter-injection and inter-observer agreement for both the presence and grade of pulmonary right-to-left shunts. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12471-018-1094-4) contains supplementary material, which is available to authorized users. Bohn Stafleu van Loghum 2018-03-01 2018-04 /pmc/articles/PMC5876176/ /pubmed/29497946 http://dx.doi.org/10.1007/s12471-018-1094-4 Text en © The Author(s) 2018 https://creativecommons.org/licenses/by/4.0/Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Vorselaars, V. M. M.
Velthuis, S.
Huitema, M. P.
Hosman, A. E.
Westermann, C. J. J.
Snijder, R. J.
Mager, J. J.
Post, M. C.
Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
title Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
title_full Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
title_fullStr Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
title_full_unstemmed Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
title_short Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
title_sort reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876176/
https://www.ncbi.nlm.nih.gov/pubmed/29497946
http://dx.doi.org/10.1007/s12471-018-1094-4
work_keys_str_mv AT vorselaarsvmm reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT velthuiss reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT huitemamp reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT hosmanae reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT westermanncjj reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT snijderrj reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT magerjj reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia
AT postmc reproducibilityofrighttoleftshuntquantificationusingtransthoraciccontrastechocardiographyinhereditaryhaemorrhagictelangiectasia